C. Roche

发表

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.

V. Richard, C. Morisseau, D. Guerrot, 2015, Prostaglandins & other lipid mediators.

Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans.

V. Richard, M. Audrézet, D. Guerrot, 2015, Kidney international.

Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors

V. Richard, C. Thuillez, R. Joannidés, 2017, Journal of hypertension.

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients

V. Richard, F. Stanke-Labesque, C. Morisseau, 2021, Scientific Reports.

A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation

F. Lamoureux, C. Thuillez, R. Joannidés, 2017, Analytical and Bioanalytical Chemistry.

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases

F. Lamoureux, D. Guerrot, J. Bellien, 2014, Expert opinion on drug discovery.

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients

V. Richard, A. Cailleux, C. Morisseau, 2019, Cardiovascular Diabetology.

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome

P. Mulder, V. Richard, D. Guerrot, 2021, Frontiers in Molecular Biosciences.

Cardiovascular Consequences of Obesity and Type 2 Diabetes Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice

P. Mulder, V. Richard, C. Morisseau, 2015 .

Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.

C. Morisseau, D. Coquerel, J. Bellien, 2015, American journal of physiology. Heart and circulatory physiology.